Fesarius Therapeutics Raises $20 Million Series A to Expand Commercial Adoption of DermiSphere

Fesarius Therapeutics has closed an oversubscribed $20 million Series A financing round to accelerate commercialization of its DermiSphere dermal regeneration... Read More

The post Fesarius Therapeutics Raises $20 Million Series A to Expand Commercial Adoption of DermiSphere appeared first on citybiz.